Esperion Therapeutics Balance Sheet - Annual (NASDAQ:ESPR)

Add to My Stocks
$48.8 $1.09 (2.28%) ESPR stock closing price Jul 24, 2017 (Closing)

The Esperion Therapeutics balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Financial strength can be guaged by performing Esperion Therapeutics stock analysis and by analyzing the balance sheet. Quarterly results are typically accompanied with the company releasing financial statements. Esperion Therapeutics had a long term debt of $1.02M at the end of 2016. View latest and last 10 year balance sheet data to check Esperion Therapeutics financial performance..

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011
Cash38.16M77.33M85.03M56.53M6.51M1.57M
Marketable Securities173.41M134.92M20.8M3.52M--
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets1.99M2.13M0.92M0.55M0.62M0.29M
Esperion Therapeutics Total Current Assets
213.57M214.39M106.76M60.61M7.13M1.86M
Property Plant & Equipment1.28M1.16M1.18M0.76M--
Accumulated Depreciation0.6M0.35M0.4M0.68M--
Esperion Therapeutics Net Property Plant & Equipment
0.67M0.8M0.78M0.08M0.12M0.25M
Investment & Advances30.9M80.31M35.74M17.53M--
Other Non-Current Assets------
Deferred Charges------
Intangibles0.05M0.05M0.05M0.05M0.05M0.05M
Deposits & Other Assets-----0.01M
Esperion Therapeutics Total Assets
245.21M295.57M143.34M78.29M7.31M2.17M
Notes Payable------
Accounts Payable4.59M0.7M2.04M2.23M0.47M0.69M
Current Portion Long-Term Debt1.7M1.6M0.63M-15.24M-
Current Portion Capital Leases------
Accrued Expenses9.28M3.31M2.81M1.97M1.19M0.2M
Income Taxes Payable------
Other Current Liabilities----0.26M0.44M
Esperion Therapeutics Total Current Liabilities
15.58M5.62M5.49M4.2M17.17M1.33M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt1.02M2.68M4.29M-7.52M6.89M
Non-Current Capital Leases------
Other Long-Term Liabilities------
Esperion Therapeutics Total Liabilities
16.61M8.31M9.79M4.2M24.7M8.23M
Minority Interest------
Preferred Stock----23.97M23.97M
Common Stock Net0.02M0.02M0.02M0.01M--
Capital Surplus457.95M441.94M238.03M142.14M0.6M0.2M
Retained Earnings-229.2M-154.22M-104.43M-68.06M-41.97M-30.23M
Treasury Stock------
Other Liabilities-0.17M-0.48M-0.05M---
Esperion Therapeutics Shareholders Equity
228.6M287.25M133.55M74.09M-17.38M-30.03M
Esperion Therapeutics Total Liabilities & Shareholders Equity
245.21M295.57M143.34M78.29M7.31M2.17M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

Looking at Esperion Therapeutics historical stock prices and the current Esperion Therapeutics stock price can tell you how the stock price has moved, whereas the Esperion Therapeutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:
  • Assets: An asset is a resource that a corporation like Esperion Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ESPR stock as of year is $245.21M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ESPR stock had total liabilities of $16.61M for year 2016.
.